Open Beta
TREN
MetriLume
TREN

US marketsEMMA

SEC-sourced researchBeta

EMMA

Emmaus Life Sciences, Inc.

Company comparison ↗

Data passport

CIK
0000822370
Exchange
OTC
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 2, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 16,653,000.0000 USD; December 2025: 12,453,000.0000 USD16.7M USD0 USD0December 2024December 2025
EMMA · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202416,653,000.0000Mar 31, 2026
December 202512,453,000.0000Mar 31, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202512,453,000.0000-7,492,000.0000-11,000.000021,436,000.000085,044,000.0000Mar 31, 2026
December 202416,653,000.0000-6,453,000.0000-2,286,000.000023,602,000.000080,081,000.0000Mar 31, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$12.45MDecember 2025Mar 31, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$16.65MDecember 2024Mar 31, 202610-K
Net incomeNetIncomeLoss-$7.49MDecember 2025Mar 31, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$11KDecember 2025Mar 31, 202610-K
Total assetsAssets$21.44MDecember 2025Mar 31, 202610-K
Total liabilitiesLiabilities$85.04MDecember 2025Mar 31, 202610-K

New filings

Explore methodology ↗